Nova Patents
IS6344A

Pharmaceutical compositions providing enhanced drug concentrations

Abstract

This record has no abstract on file.

Term

Term ended

Projected expiry passed 16 April 2022, 4.4 years ago.

  1. Priority
  2. Filed and published
  3. Projected expiry
  4. Today

58 members in 33 offices

This recordMember, by publication datePriority claim23 more offices are in the list below

Priority claims7

Priority claims
DocumentOfficeKindDate
17184199United States of AmericaP
17184199United States of AmericaP
0001787International Bureau of the World Intellectual Property Organization (WIPO)W
0001787International Bureau of the World Intellectual Property Organization (WIPO)W
PCTIB0001787–––
US19990171841P–––
WO2000IB01787–––

Members58

Family members, oldest first
DocumentOfficeKind
CA2395331A1CanadaA1
WO0147495A1World Intellectual Property Organization (WIPO)A1
AU1409101AAustraliaA
UY26496A1UruguayA1
US2002006443A1United States of AmericaA1
IS6344AThis recordIcelandA
TNSN00252A1TunisiaA1
NO20022998D0NorwayD0
AP2002002552A0African Regional Intellectual Property Organization (ARIPO)A0
SV2002000248AEl SalvadorA
NO20022998LNorwayL
KR20020068061ARepublic of KoreaA
BR0016555ABrazilA
EP1239835A1European Patent Office (EPO)A1
TR2002001617T2TürkiyeT2
TR200201617T2TürkiyeT2
EA200200431A1Eurasian Patent Organization (EAPO)A1
IL149186A0IsraelA0
MXPA02006324AMexicoA
AR027065A1ArgentinaA1
CN1402629AChinaA
BG106764ABulgariaA
CO5261563A1ColombiaA1
HU0204372A2HungaryA2
HUP0204372A2HungaryA2
JP2003518485AJapanA
CZ20022047A3CzechiaA3
SK8562002A3SlovakiaA3
EE200200357AEstoniaA
ZA200204962BSouth AfricaB
CR6654ACosta RicaA
HRP20020531A2CroatiaA2
HU0204372A3HungaryA3
HUP0204372A3HungaryA3
PL357470A1PolandA1
MA26853A1MoroccoA1
GEP20053427BGeorgiaB
EA006402B1Eurasian Patent Organization (EAPO)B1
KR100558239B1Republic of KoreaB1
AU784340B2AustraliaB2
OA12124AAfrican Intellectual Property Organization (OAPI)A
EP1712222A2European Patent Office (EPO)A2
EP1738749A1European Patent Office (EPO)A1
JP2008101004AJapanA
CA2395331CCanadaC
US8026286B2United States of AmericaB2
US2011294902A1United States of AmericaA1
US8202912B2United States of AmericaB2
EP1712222A3European Patent Office (EPO)A3
US2012259022A1United States of AmericaA1
EP1239835B1European Patent Office (EPO)B1
US8501231B2United States of AmericaB2
US2013345236A1United States of AmericaA1
US8796341B2United States of AmericaB2
US2014322325A1United States of AmericaA1
US8980321B2United States of AmericaB2
US2015190518A1United States of AmericaA1
US9457095B2United States of AmericaB2